In this Supplement
Choosing the Best Option Through Data-Informed Decision Making
By Michael R. Jaff, DO
A look at the latest data on use of the Eluvia drug-eluting stent in challenging SFA lesions.
By Theodosios Bisdas, MD, PhD
What these findings tell us about the safety and efficacy of the Ranger drug-coated balloon.
With Dierk Scheinert, MD
These evolving modern therapies are showing promise in reducing health care costs while offering better outcomes.
By Konstantinos Katsanos, MSc, MD, PhD, EBIR
The anatomic factors that make longer DCBs the ideal choice for treating longer, more difficult lesions.
By Gunnar Tepe, MD
The merits of a two-part approach in the SFA and popliteal artery.
By Ulrich Sunderdiek, MD, PhD
Promising results for drug-eluting stent use in CLI patients with lesions below the knee.
By Hans van Overhagen, MD, PhD, EBIR
The unique features of this disease are finally being addressed with new devices.